A new study has found immunotherapy to be more effective than chemotherapy in treating most previously treated patients with advanced lung cancer, and demonstrated effectiveness in a wider population of people than previously known to benefit from the therapy.
A first-of-its-kind (anti-PD-1) immunotherapy was approved today by the U.S. Food & Drug Administration as first-line treatment for metastatic melanoma—allowing greater access to this therapy for patients without having to previously receive other prior treatments.
UCLA researchers have found that space-mapping neurons – the GPS system in the brain - have a strong dependence on what is being looked at when triangulating location, a finding that resolves a neurological mystery that has vexed scientists for more than four decades.
Rickety rungs on ladders and tipsy tree trimmers are two of many factors that can lead from happily decking the halls and rooftops to not-so-festively donning stitches and casts. Dr. Wally Ghurabi, medical director of the Nethercutt Emergency Center at UCLA Medical Center, Santa Monica, offers tips on how to avoid injuries while decorating for the holidays.
A program launched earlier this year by UCLA and three other top research universities has formed an educational partnership with the U.S. Department of Veterans Affairs. The partnership, between the National Clinician Scholars Program and the VA, will allow the next generation of leaders and change agents to understand and improve the health of veterans, and of the nation.
A new study validates a widely-used program for combatting psychological and emotional challenges faced by military families.
Children’s Hospital Los Angeles announces the availability of the EOS Imaging System, the first technology capable of providing head-to-toe images of patients in both 2D and 3D while using up to 90 percent less radiation than X-rays.
A UCLA researcher has analyzed the long-term outcomes in postmenopausal women who took two widely used breast cancer treatments and found that although both drugs were safe and effective, and had no detrimental effect on overall quality of life, there were some differences in the type and severity of symptoms the women experienced with each treatment, and these especially differed by age.
A team of UCLA researchers found that there are several parts of California where, in a high percentage of people with thyroid cancer, the disease is already at an advanced stage by the time it is diagnosed.
Dozens of the country’s leading experts in gynecology and related specialties are asking the Food and Drug Administration to rescind or revise a warning it issued severely restricting use of a device commonly employed in minimally invasive procedures to treat uterine fibroids.
UCLA Health Sciences has received a $10 million gift, most of which will support multidisciplinary research on migraine, a debilitating neurological disorder that affects 36 million in the U.S.
Distractions while driving can come from visual, physical, and cognitive sources. A special section of the December 2015 Human Factors presents a framework for measuring cognitive distraction, followed by expert commentaries that suggest a way forward for reducing crash risk.
In the first study of its kind, researchers have shown that inadequate maternal iron intake during pregnancy exerts subtle effects on infant brain development. Their findings have been published online by the journal Pediatric Research.
USC Annenberg Professor and award-winning documentarian Dan Birman has landed the rights to produce the bestselling seven-volume book series Hinges of History, by revered scholar and historical author Thomas Cahill.
Clinical trials that lay the groundwork for novel leukemia and lymphoma treatments will be among the highlights of the annual meeting of the American Society of Hematology (ASH) getting under way this week in Orlando. The trials, presented by researchers and physicians from City of Hope, could ultimately lead to innovative therapeutic approaches that improve survival and quality of life for patients with those and other diseases.
The Leapfrog Group has named Children’s Hospital Los Angeles as a Leapfrog Top Hospital for 2015. The designation is considered one of the hospital industry’s elite benchmarks of patient safety and quality care and Children’s Hospital Los Angeles is the only pediatric medical center in Los Angeles County to receive the distinction.
Fans can bid on ornaments signed by Heidi Klum, Drew Barrymore, Bradley Cooper, Josh Gad, LL Cool J, Selena Gomez, Adam Levine, Gwen Stefani, Chris O’Donnell, Pharrell Williams, Sarah Chalke, Caitlyn Jenner, Kylie Jenner and Speck iPad Air cases signed by Spike Lee, Jack Black, Kevin Bacon, James Franco, Ryan Reynolds and Connie Britton, among others
For people who have battled cancer, every new day is a new adventure. No one knows that better than the cancer doctor, nurse researcher and five cancer patients who will be riding City of Hope’s float at the 127th Tournament of Roses Parade on New Year’s Day.
An increasing number of men diagnosed with low-risk prostate cancer are opting for active surveillance – closely monitoring their cancer – rather than aggressive treatment to avoid the debilitating potential side effects of surgery and radiation.
Genetic variation in patients with inflammatory bowel disease (IBD) appears to play a major role in determining how sick they will become and could provide a road map for more effective treatments.
Taking the pregnancy hormone estriol along with their conventional medications helped patients with relapsing-remitting multiple sclerosis (RRMS) avoid relapses, according to results of a Phase II randomized, placebo-controlled study led by UCLA researchers.
Individuals with autism spectrum disorder (ASD) often have difficulty recognizing and interpreting how facial expressions convey various emotions – from joy to puzzlement, sadness to anger. This can make it difficult for an individual with ASD to successfully navigate social situations and empathize with others.
With the holidays approaching, the humble pumpkin has taken its rightful place center stage. One of the most versatile of fruits, almost every part of the pumpkin is edible – flowers, leaves, meat, seeds and oil – and virtually all offer health benefits.
With open enrollment for the Covered California health exchange now underway, City of Hope has announced an agreement with Blue Shield of California to participate in the insurer’s Individual and Family Plan products.
Steven T. Rosen, M.D., provost and chief scientific officer for City of Hope, will receive a Lifetime Achievement Award from the Israel Cancer Research Fund (ICRF) on Nov. 18 at a Chicago gala attended by hundreds of supporters of cancer research. The award recognizes Rosen’s longstanding commitment to advancing science and medicine and providing extraordinary patient care.
In a clinical trial to be launched at City of Hope in November, researchers Don J. Diamond, Ph.D., Vincent Chung, M.D., and their collaborators will combine an immune-boosting vaccine and a drug that blocks a tumor’s inhibitory signal to more effectively activate a patient’s own immune system to fight his or her cancer.
Harnessing the power of social media, investigators have sifted through more than two billion tweets and online posts to study the harmful side effects of narcotics medication taken for chronic pain.
Children’s Hospital Los Angeles (CHLA) announced tthat it has been recognized as a Top Performer on Key Quality Measures® for 2015 (based on 2014 data) for its childhood asthma care by the Joint Commission, the leading accreditor of health care organizations in the United States.
CLA researchers have found that a drug that inhibits a receptor called the Colony-Stimulating-Factor-1 Receptor, or CSF1R, reduces ascites with minimal side effects.
A new workbook by a UCLA expert in recovering from alcoholism and drug addiction lays out an array of approaches, including one that emphasizes looking for enjoyment in all the right places.
New Research in Cell Host & Microbe Indicates Commonly Prescribed Antibiotic Could Potentially Worsen Methicillin-Resistant Staphylococcus Aureus
Chest pain in female-pattern heart disease is linked with abnormal heart blood flow, demonstrated with a drug commonly used to alleviate chest pain patients with coronary artery disease, which was found to be ineffective in patients with moderate female-pattern heart disease, but may offer some relief for sicker patients, a new Cedars-Sinai Heart Institute study shows. The study’s results were presented today as a late-breaking trial at the American Heart Association Scientific Sessions in Orlando.
Wrist fractures are common among postmenopausal women who are younger than 65 and a new UCLA-led study suggests that they may also predict more serious fractures in other parts of their bodies later in life. The researchers on the study, published in the November issue of the Journal of Bone and Mineral Research, found that one in five women who had experienced a broken wrist went on to suffer a non-wrist fracture during the next 10 years.
FDA today approved a new therapy that combines vemurafenib (Zelboraf), a drug used to treat melanoma, with cobimetinib (Cotellic). Study conducted at UCLA and other sites internationally showed significantly improved response rates to the therapy in men and women with advanced melanoma with a BRAF mutation.
Throughout her childhood, Blanca's doctors couldn't figure out why she had an enlarged liver, diagnosing her with everything from cirrhosis to hepatitis. But when she was referred to CHLA, cardiologist Dr. Frank Ing discovered the problem wasn't her liver at all. (Video Available)
Human factors/ergonomics researchers examined the relationship between U.S. voting system usability and the polling station environment because these systems are so diverse and little is understood about the impact of one on the other. The study reveals that if environmental features and system attributes deter people from voting, it could lead to altered election outcomes.
The nation’s pre-eminent center for health journalism training and news collaborations today announced a name change: the Center for Health Journalism.
The National Institutes of Health has awarded City of Hope a five-year, $4.8 million grant to study the possible role of chemicals in the environment in the development of breast cancer during the menopausal transition in women.
The National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) has awarded a $2.2 million grant to help City of Hope researchers explore the underlying mechanisms of graft-versus-host disease, the leading cause of long-term sickness and death following transplantation of bone marrow cells from a donor.
Renowned health care leader Glenn D. Steele Jr., M.D., Ph.D., the recent past president and chief executive officer of Geisinger Health System, will join the City of Hope board of directors beginning Jan. 1, 2016.
Starting today and extending through the end of the year, CHLA's Live L.A. Give L.A. campaign raises funds that will directly support care for the children of Los Angeles. Providing the finest pediatric medical care and research comes with an immense cost—and the needs are urgent. A gift to the Live L.A. Give L.A. campaign helps safeguard the community’s sickest children by providing the support that the nonprofit pediatric hospital needs to conduct leading-edge research and ensure that critical, lifesaving care is available to every child the hospital treats.
UCLA researchers looked at the five components of a primary care medical home and found that one factor--having a usual source of care--was the most reliable predictor of whether a child would be readmitted to a hospital or emergency room within a month after being discharged.
Investigators at Children’s Hospital Los Angeles now report that platinum-based chemotherapy may not only impact hearing, but that the hearing loss may then contribute to long-term neurocognitive deficits.
Now, for the first time, UCLA researchers have described cost across an entire care process for low-risk prostate cancer – from the time a patient checks in for his first appointment to his post-treatment follow-up testing - using time-driven activity-based costing.
Renowned health care leader Glenn D. Steele Jr., M.D., Ph.D., the recent past president and chief executive officer of Geisinger Health System, will join the City of Hope board of directors beginning Jan. 1, 2016.
Called “The Miracle of Science with Soul,” the new campaign is the first-ever broad communications program by City of Hope, which pioneered the technology behind cancer treatment game-changers trastuzumab (Herceptin®), bevacizumab (Avastin®) and rituximab (Rituxan®), as well as synthetic human insulin for the treatment of diabetes. The campaign is centered around the real stories of six patients who showcase how City of Hope fuses science and research innovation with compassionate care in order to save lives.
UCLA Health is launching a crowdfunding campaign to support its animal-assisted therapy program.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right